Gastrointestinal Bleeding Clinical Trial
Official title:
Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices
Terlipressin is an effective and safe treatment for bleeding caused by rupture of
oesophageal varices, which are life-threatening complications of liver cirrhosis.
Oesophageal varices are abnormal dilatation of veins occurring in the lower oesophagus,
which can develop in patients with cirrhosis. Bleeding caused by rupture of these varices is
a life-threatening complication with mortality between 20-50%.
Such bleeding can be treated with drug therapy and/or endoscopic; endoscopic therapy
consists of a flexible tube equipped with a camera at the terminal end, allowing for
visualizing and treating the oesophageal varices.
In this study, investigators will evaluate the safety and efficacy of terlipressin -
Glypressin 1 mg, powder and solvent for solution for injection.
The non-interventional observational study "Follow-up of Glypressin (terlipressin) clinical
efficacy in the treatment of bleeding oesophageal varices" aims to demonstrate that
administration of Glypressin (terlipressin 1 mg) controls the bleeding in such patients.
n/a
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05060731 -
Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding
|
Phase 4 | |
| Recruiting |
NCT05949268 -
Video Capsule Endoscopy for Detection of Gastrointestinal Bleeding in the Small Bowel
|
||
| Not yet recruiting |
NCT03243240 -
Computed Tomography in Gastrointestinal Bleeding
|
N/A | |
| Completed |
NCT02595853 -
Efficacy of a Novel Hemostatic Powder in GI Bleeding
|
||
| Completed |
NCT01434108 -
Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
|
Phase 2/Phase 3 | |
| Terminated |
NCT01756690 -
Predicting Lung Injury From Transfusion in Patients With Liver Disease
|
N/A | |
| Completed |
NCT01424254 -
The Effectiveness of Video-capsule Endoscopy in Gastrointestinal Bleeding of Obscure Origin
|
Phase 3 | |
| Completed |
NCT05884931 -
Effectiveness and Safety of Nexpowder as an Endoscopic Hemostatic Treatment
|
N/A | |
| Withdrawn |
NCT00401908 -
Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding
|
N/A | |
| Recruiting |
NCT05024864 -
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in MI Patients
|
N/A | |
| Completed |
NCT05008640 -
Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™
|
||
| Recruiting |
NCT06259292 -
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
|
||
| Completed |
NCT03716466 -
Evaluation of Prophylactic Endotracheal Intubation
|
||
| Completed |
NCT05362227 -
High-Volume Vs Low-Volume Preparation in Emergency Department
|
N/A | |
| Completed |
NCT02405286 -
Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage
|
N/A | |
| Recruiting |
NCT00562445 -
Adrenal Insufficiency in Critical Emergencies in Digestive Diseases
|
N/A | |
| Recruiting |
NCT05290857 -
Anticoagulation After GI Bleeding Pilot Study and Registry
|
N/A | |
| Recruiting |
NCT02863250 -
Australian and New Zealand Massive Transfusion Registry
|
||
| Completed |
NCT01415869 -
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
|
||
| Completed |
NCT01821326 -
Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding
|
N/A |